BPCE
CELG

Bank Pictet & Cie (Europe)’s Celgene Corp CELG Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,700
Closed -$2.28M – 187
2016
Q4 		$2.28M Sell
19,700
-700
-3% -$78K 0.38% 55
2016
Q3 		$2.13M Buy
+20,400
New +$2.21M 0.39% 57

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s CELG Position: Q4 2019 in Review

Bank Pictet & Cie (Europe) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 118,380 shares — an estimated $11.8M sold.

Bank Pictet & Cie (Europe) first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $27.6M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bank Pictet & Cie (Europe) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 118,380 Celgene Corp shares in Q4 2019, an estimated $11.8M.
  • Bank Pictet & Cie (Europe) first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • Bank Pictet & Cie (Europe)'s Celgene Corp position peaked at $27.6M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2019, filed 31 Jan 2020.